Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 73 5
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
Anakinra  Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022 57 5
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021 26 15
Epigallocatechin Gallate Potential treatment - pre-clinical evidence Natural product Antiviral Apr/08/2021 11 0
N-acetylcysteine Potential treatment - pre-clinical evidence Used to treat other disease Other treatment Mar/06/2021 2 1
Tipiracil  Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/09/2021 2 0
Theaflavin Potential treatment - pre-clinical evidence Natural product Antiviral Dec/09/2020 2 0
Excel (.xslx) CSV (.csv)